SHMN Stock Overview
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
SOHM, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0018 |
| 52 Week High | US$0.0022 |
| 52 Week Low | US$0.0005 |
| Beta | 0 |
| 1 Month Change | 38.46% |
| 3 Month Change | -5.26% |
| 1 Year Change | 100.00% |
| 3 Year Change | -78.05% |
| 5 Year Change | 200.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| SHMN | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 20.0% | 0.9% | 1.2% |
| 1Y | 100.0% | 13.9% | 24.7% |
Return vs Industry: SHMN exceeded the US Pharmaceuticals industry which returned 13.9% over the past year.
Return vs Market: SHMN exceeded the US Market which returned 24.7% over the past year.
Price Volatility
| SHMN volatility | |
|---|---|
| SHMN Average Weekly Movement | 22.0% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SHMN's share price has been volatile over the past 3 months.
Volatility Over Time: SHMN's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Shailesh Shah | www.sohm.com |
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products.
SOHM, Inc. Fundamentals Summary
| SHMN fundamental statistics | |
|---|---|
| Market cap | US$2.88m |
| Earnings (TTM) | -US$1.13m |
| Revenue (TTM) | US$1.30m |
0.0x
P/S Ratio0.0x
P/E RatioIs SHMN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHMN income statement (TTM) | |
|---|---|
| Revenue | US$1.30m |
| Cost of Revenue | US$962.58k |
| Gross Profit | US$333.87k |
| Other Expenses | US$1.47m |
| Earnings | -US$1.13m |
Last Reported Earnings
Dec 31, 2012
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SHMN perform over the long term?
See historical performance and comparison